Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Innoviva Stock (NASDAQ: INVA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 517.09K |
Day Range | - - - |
52 Wk Range | 12.22 - 19.85 |
Market Cap | $1.22B |
P/E Ratio | 11.01 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 35.95% |
Days to Cover | 28.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Innoviva (NASDAQ:INVA) through any online brokerage.
Other companies in Innoviva’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).
Innoviva has a consensus price target of $15.17.
The stock price for Innoviva (NASDAQ: INVA) is $19.48 last updated September 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Innoviva.
Innoviva’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Innoviva.
Innoviva is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.